Cointime

Nagi Bioscience

company

About

Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested.

  • 1 - 10

Highlights

Total Funding Amount
Fr1.80M €2.50M
Funding Rounds
2
Investors
3

Details

Last Funding Type
Seed
Last Funding Money Raised
Fr1.80M
Industries
Biotechnology
Founded date
Jan 1, 2019
Number Of Employee
1 - 10
Operating Status
Active

Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested today, by introducing the first “Organism-on-Chip” technology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
Fr1.80M €2.50M
Nagi Bioscience has raised a total of Fr1.80M €2.50M in funding over 2 rounds. Their latest funding was raised on Mar 21, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 21, 2022 Grant €2.50M 1 European Innovation Council — Detail
Dec 20, 2019 Seed Fr1.80M 2 Verve Ventures — Detail

Investors

Number of Lead Investors
Number of Investors
2
3
Nagi Bioscience is funded by 3 investors. European Innovation Council and Verve Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Grant
Verve Ventures Yes Seed
NEST pension fund — Seed
Cointime
เนื้อหา
บริษัท